Aqueous retarded acid solution and methods for use thereof
US-2016298024-A1 · Oct 13, 2016 · US
US12091610B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12091610-B2 |
| Application number | US-202318305765-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 24, 2023 |
| Priority date | Sep 3, 2015 |
| Publication date | Sep 17, 2024 |
| Grant date | Sep 17, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein is a multi-phase aqueous composition containing a surfactant; a first phase comprising water, an acid, and a water-soluble acid retarding agent; and a second phase selected from the group consisting of an immiscible organic phase, a gas, and combinations thereof. Further described are methods of making and using such compositions.
Opening claim text (preview).
What is claimed is: 1. A treatment fluid, comprising: an emulsion of an aqueous phase and an organic phase, the emulsion stabilized using an ethoxylated nonionic surfactant; wherein the aqueous phase comprises an acid having 15% weight by volume (w/v) of hydrochloric acid (HCl) and a water-soluble acid retarding agent having 19% w/v of magnesium chloride (MgCl 2 ). 2. The treatment fluid of claim 1 , wherein a water concentration of the emulsion is less than or equal to 80 wt % based on a total weight of the emulsion. 3. The treatment fluid of claim 1 , wherein the aqueous phase of the emulsion is about 70% by volume, and the organic phase of the emulsion is about 30% by volume. 4. The treatment fluid of claim 1 , wherein the ethoxylated nonionic surfactant comprises the structure RO(CH 2 CH 2 O) n H, wherein R is an alkyl group of 6 to 18 carbons, and 1≤n≤10. 5. The treatment fluid of claim 1 , wherein the treatment fluid is configured to treat a subterranean formation fluidly coupled to a wellbore, wherein the acid further comprises hydrogen bromide, hydrogen iodide, hydrogen fluoride, sulfuric acid, nitric acid, phosphoric acid, alkanesulfonic acids, arylsulfonic acids, acetic acid, formic acid, alkyl carboxylic acids, acrylic acid, lactic acid, glycolic acid, malonic acid, fumaric acid, citric acid, tartaric acid, or combinations thereof. 6. The treatment fluid of claim 1 , wherein the treatment fluid comprises a chelating agent. 7. The treatment fluid of claim 6 , wherein the chelating agent comprises polycarboxylic acids. 8. The treatment fluid of claim 1 , wherein the ethoxylated nonionic surfactant stabilizes an oil-in-acid (O/A) emulsion. 9. The treatment fluid of claim 1 , wherein the organic phase comprises alkanes, cycloalkanes, aromatic compounds, heteroaromatic compounds, or any combination thereof.
in situ inhibition of corrosion in boreholes or wells · CPC title
combined with additives added for specific purposes · CPC title
Foams · CPC title
by use of eroding chemicals, e.g. acids · CPC title
Compositions based on water or polar solvents (C09K8/64 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.